RecruitingNot ApplicableNCT04093388

Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama


Sponsor

University of Alabama at Birmingham

Enrollment

250 participants

Start Date

Apr 26, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the study is to find out if a self-administered (by the patient) Papanicolaou (Pap) smear is as accurate as a traditional Pap smear administered by a healthcare provider.


Eligibility

Sex: FEMALEMin Age: 21 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether women in rural Alabama can collect their own cervical cancer screening sample (like a Pap smear) at home, instead of having it done by a healthcare provider. The goal is to make cervical cancer screening easier and more accessible for women who don't regularly get screened. **You may be eligible if...** - You are a woman between 21 and 65 years old - You are due for routine cervical cancer screening based on national guidelines **You may NOT be eligible if...** - You have a history of cervical cancer or a previously abnormal Pap smear - You have had a total hysterectomy (removal of both uterus and cervix) - You are currently enrolled in another cancer prevention study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTSelf-PAP

A single cohort of 250 patients will be recruited from among those who need a Papanicolaou (Pap) smear for routine cervical cancer screening, to perform a self-administered Pap smear immediately prior to the traditional Pap smear. Blinded assessment of both tests will be then conducted.

DIAGNOSTIC_TESTTraditional Pap smear

A single cohort of 250 patients will be recruited from among those who need a Papanicolaou (Pap) smear for routine cervical cancer screening, to perform a self-administered Pap smear immediately prior to the traditional Pap smear. Blinded assessment of both tests will be then conducted.


Locations(3)

Cahaba Medical Care - West End

Birmingham, Alabama, United States

Cahaba Medical Care - Ensley

Birmingham, Alabama, United States

Cahaba Medical Care

Centreville, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04093388


Related Trials